Compared with patients excluded due to prior kidney disease (n = 2,836), the study cohort had higher median eGFR (88.7 vs. 56.7 mL/min/1.73 m2), lower median CRP (4.0 vs. 16.0 mg/L), and lower median suPAR (2.7 vs. 4.5 ng/mL) (all P < 0.001). Here, CRP is linked to kidney disorder.